Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (82% survival) in over 5000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine. ECMO is currently the treatment of choice for full-term newborns with severe respiratory failure. The report summarizes indications, resulting complications, and future applications of neonatal ECMO.

Original languageEnglish
Pages (from-to)316-322
Number of pages7
JournalThoracic and Cardiovascular Surgeon
Issue number6
StatePublished - 1992


  • Extracorporeal Life Support Organization
  • complications
  • extracorporeal oxygenation
  • indications
  • membrane oxygenation

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure'. Together they form a unique fingerprint.

Cite this